Dr Michel Dorval is Full Professor at the Faculty of Pharmacy. He holds a Master’s degree in Psychology (1984) and a Doctorate in Epidemiology (1997) from Université Laval, complemented by postdoctoral training from Dana-Farber Cancer Institute (Harvard Medical School) thanks to a Terry Fox Fellowship from the National Cancer Institute of Canada. From 1999 to 2011, he constantly held research career awards (Junior I, Junior II, Senior) from the Fonds de la recherche du Québec-Santé (FRQS).

Since the beginning of his career, Dr. Dorval has used a variety of methodological approaches, both quantitative and qualitative, to better understand the impact of breast cancer at all stages of the disease on patients, women at risk and their families. He has always demonstrated a commitment to improving health services through active involvement in knowledge translation. For example, the results of his work led to the creation in 2012 of Centre ROSE (Ressources en Oncogénétique pour le Soutien et l’Éducation), which he co-founded with his colleague Dr. Jocelyne Chiquette. The mission of Centre ROSE was to inform and support people with hereditary cancer risk, and to provide evidence-based tools to health professionals. Center ROSE has received several awards, including the Hommage aux Innovations Sociales from Université Laval (2014), the Prix d’Excellence Innovation dans la Communauté from the Quebec Breast Cancer Foundation (2016) and the Prix Promotion de la Santé et Prévention from the Direction générale de cancérologie du Québec (2016). In 2015, Centre ROSE evolved into Réseau ROSE (www.reseaurose.ca) by adding satellites in various regions of Quebec. As a continuation of the Réseau ROSE, work is underway since 2020 under the aegis of RUISSS-UL to create the Réseau en Oncogénétique de l’Est du Québec.

In addition to his work on breast cancer, Dr. Dorval has always been interested in palliative care. He is a member of the research team at the Maison Michel-Sarrazin and of the Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL) since its founding. He is currently leading an interdisciplinary and intersectoral team whose work aims to 1) evaluate the social and professional acceptability of psilocybin-assisted therapy to relieve existential distress at the end of life, 2) identify issues to be considered for access to this innovative therapy and 3) propose recommendations establishing guidelines for the use of psilocybin for therapeutic purposes in the Quebec medico-legal context.

Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
J0-21
Québec, Québec
Canada G1S 4L8
+1 418-525-4444, extension 88047
+1 418-682-7949
Michel.Dorval@crchudequeb...

Latest news

65 entries « ‹ 1 of 7 › »

Pomey MP, Paquette J, Iliescu-Nelea M, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M

Accompanying patients in clinical oncology teams: Reported activities and perceived effects

Journal Article

Health Expect, 26 (2), 2023.

Abstract | Links:

Ouellet J, Lapointe J, Raîche C, Guerin A, Helal S, Fitzpatrick J, Dorval M, Nabi H

Scope of coverage of medical genetics and genomics in pre-clerkship programs of Canadian faculties of medicine: A curriculum analysis

Journal Article

Am J Med Genet A, 191 (1), 2023.

Abstract | Links:

Espinoza Moya ME, Guertin JR, Dorval M, Lapointe J, Bouchard K, Nabi H, Laberge M

Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol

Journal Article

BMJ Open, 12 (12), 2022.

Abstract | Links:

Lapointe J, Buron AC, Mbuya-Bienge C, Dorval M, Pashayan N, Brooks JD, Walker MJ, Chiquette J, Eloy L, Blackmore K, Turgeon A, Lambert-Côté L, Leclerc L, Dalpé G, Joly Y, Knoppers BM, Chiarelli AM, Simard J, Nabi H

Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals

Journal Article

Genet Med, 24 (11), 2022.

Abstract | Links:

Charron M, Kaiser B, Dauge A, Gallois H, Lapointe J, Dorval M, Nabi H, Joly Y

Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges

Journal Article

Crit Rev Oncol Hematol, 178 , 2022.

Abstract | Links:

Hébert J, Bergeron AS, Veillette AM, Bouchard K, Nabi H, Dorval M

Issues associated with a hereditary risk of cancer: Knowledge, attitudes and practices of nurses in oncology settings

Journal Article

Can Oncol Nurs J, 32 (2), 2022.

Abstract | Links:

Hébert J, Bergeron AS, Veillette AM, Bouchard K, Nabi H, Dorval M

Enjeux associés au risque héréditaire de cancer: connaissances, attitudes et pratiques infirmières en oncologie

Journal Article

Can Oncol Nurs J, 32 (2), 2022.

| Links:

Ahmed S, Lévesque E, Garland R, Knoppers B, Dorval M, Simard J, Loiselle CG

Women's perceptions of PERSPECTIVE: a breast cancer risk stratification e-platform

Journal Article

Hered Cancer Clin Pract, 20 (1), 2022.

Abstract | Links:

Barrault-Couchouron M, Béracochéa M, Dorval M, Allafort V, Barthélémy V, Garguil V, Auriacombe M, Bussières E, M'bailara K

[Tobacco and alcohol consumption in women treated for breast cancer in a department of surgical oncology: Frequent behaviours to consider]

Journal Article

Bull Cancer, 109 (3), 2022.

Abstract | Links:

Cléophat JE, Dorval M, El Haffaf Z, Chiquette J, Collins S, Malo B, Fradet V, Joly Y, Nabi H

Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings

Journal Article

BMC Med Genomics, 14 (1), 2021.

Abstract | Links:

65 entries « ‹ 1 of 7 › »
Signaler des ajouts ou des modifications

Active projects

  • Comprendre le lien entre le jeu problématique et les troubles psychotiques chez les jeunes : une nouvelle voie vers le rétablissement, from 2020-03-01 to 2024-12-31
  • Exploring the impact for COVID-19 pandemic on women with breast cancer in Quebec, from 2021-12-01 to 2023-09-30
  • La psilocybine pour soulager la détresse existentielle en fin de vie: Audace, acceptabilité et accès, from 2022-04-01 to 2024-03-31
  • Personalized Risk Assesment for Prevention and Early Detection of Breast Cancer : Integration and Implementation (PERSPECTIVE II), from 2017-11-01 to 2024-03-31
  • What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, from 2022-01-15 to 2024-01-14

Recently finished projects

  • FGR - La psilocybine pour soulager la détresse existentielle en fin de vie : Audace, acceptabilité et accès, from 2021-11-12 to 2022-11-11
  • Le patient accompagnateur, une ressource organisationnelle comme levier pour une expérience patient améliorée en oncologie (PAROLE-Onco), from 2017-07-01 to 2021-06-30
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2023-03-01
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2022-03-31
  • Réseau R.O.S.E., from 2015-08-01 to 2021-07-31
Data provided by the Université Laval research projects registery